|
ZNF391 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57259999361759E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.00929955901574E-10 |
| Normal-vs-Stage2 |
8.582600E-04 |
| Normal-vs-Stage3 |
1.67129976524905E-10 |
| Normal-vs-Stage4 |
6.86650736270167E-12 |
| Stage1-vs-Stage2 |
3.043900E-02 |
| Stage1-vs-Stage3 |
4.481200E-01 |
| Stage1-vs-Stage4 |
2.378400E-02 |
| Stage2-vs-Stage3 |
1.584240E-02 |
| Stage2-vs-Stage4 |
1.881800E-03 |
| Stage3-vs-Stage4 |
1.947210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73099978795221E-10 |
| Normal-vs-AfricanAmerican |
3.77579999999433E-06 |
| Normal-vs-Asian |
2.41590003557945E-09 |
| Caucasian-vs-AfricanAmerican |
3.942600E-01 |
| Caucasian-vs-Asian |
8.953400E-01 |
| AfricanAmerican-vs-Asian |
4.834800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.56680240898299E-11 |
| Normal-vs-Female |
3.01719982331861E-10 |
| Male-vs-Female |
7.241000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.53620013879186E-10 |
| Normal-vs-Age(41-60Yrs) |
1.39139999522087E-09 |
| Normal-vs-Age(61-80Yrs) |
2.4095000439317E-09 |
| Normal-vs-Age(81-100Yrs) |
8.782700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.842400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.004000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.088600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.342200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.067400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.793200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.016500E-03 |
| Classical-VS-Follicular |
8.243600E-02 |
| Classical-VS-Other |
6.721200E-01 |
| Classical-VS-Normal |
1.07550002237389E-09 |
| Tall-VS-Follicular |
2.835500E-04 |
| Tall-VS-Other |
5.335800E-01 |
| Tall-VS-Normal |
4.13269418686468E-12 |
| Follicular-VS-Other |
3.871400E-01 |
| Follicular-VS-Normal |
4.3183999998142E-07 |
| Other-VS-Normal |
3.996200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09319999719304E-08 |
| Normal-vs-N1 |
9.23938703323302E-12 |
| N0-vs-N1 |
2.702200E-03 |
|
|
